tirzepatide phase 3 study results Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, trial Weight reduction with different doses

For example, a 2024 meta-analysis found that eating less often and consuming more calories earlier in the day was actually associated with greater weight loss compared to spreading calorie intake more evenly throughout the day or saving most for evening

Listening to the heart and lungs with a stethoscope helps check for abnormal sounds

If your flight exceeds eight hours, consider purchasing a medication cooler with ice packs or a portable insulin travel case to maintain the cold chain

Bruising occurs when injection needles damage small blood vessels in subcutaneous tissue

Thomas MK, Nikooienejad A, Bray R, Cui X, Wilson J, Duffin K, Milicevic Z, Haupt A, Robins DA (2021) Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes

Because the vast array of molecular and cellular mechanisms modulated by these two new drug classes often intercept in pathophysiological background of chronic cardiovascular and neurodegenerative diseases, it is possible that any future new anti-diabetic drug may be also relevant for cardiometabolic and cognitive decline, independently from the anti-diabetic action